ロード中...
Exenatide treatment causes suppression of serum fasting ghrelin levels in patients with type 2 diabetes mellitus
AIM: In the present study, we investigated the long-term effects of exenatide treatment on serum fasting ghrelin levels in patients with type 2 diabetes mellitus. METHODS: Type 2 diabetic patients, who were using metformin with and without the other antihyperglycemic drugs on a stable dose for at le...
保存先:
| 出版年: | Endocr Connect |
|---|---|
| 主要な著者: | , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Bioscientifica Ltd
2017
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5776666/ https://ncbi.nlm.nih.gov/pubmed/29217653 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1530/EC-17-0242 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|